iBio, Inc. (IBIO)
NASDAQ: IBIO · Real-Time Price · USD
3.910
-0.110 (-2.74%)
At close: Apr 1, 2025, 4:00 PM
3.880
-0.030 (-0.77%)
After-hours: Apr 1, 2025, 4:47 PM EDT
iBio, Inc. Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for iBio, Inc. stock have an average target of 4.87, with a low estimate of 3.60 and a high estimate of 6.00. The average target predicts an increase of 24.55% from the current stock price of 3.91.
Analyst Consensus: Strong Buy
* Price targets were last updated on Dec 17, 2024.
Analyst Ratings
The average analyst rating for iBio, Inc. stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 3 | 3 | 3 | 3 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 3 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| LUCID CAPITAL MARKETS | LUCID CAPITAL MARKETS | Strong Buy Initiates $6 | Strong Buy | Initiates | $6 | +53.45% | Dec 17, 2024 |
| Brookline Capital | Brookline Capital | Strong Buy Initiates $3.6 | Strong Buy | Initiates | $3.6 | -7.93% | Jul 22, 2024 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $5 | Strong Buy | Maintains | $5 | +27.88% | Jun 3, 2024 |
| Chardan Capital | Chardan Capital | Strong Buy Initiates $5 | Strong Buy | Initiates | $5 | +27.88% | May 28, 2024 |
| JMP Securities | JMP Securities | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Feb 16, 2023 |
Financial Forecast
Revenue This Year
306.00K
from 225.00K
Increased by 36.00%
Revenue Next Year
408.00K
from 306.00K
Increased by 33.33%
EPS This Year
-1.62
from -6.50
EPS Next Year
-1.40
from -1.62
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 630,000 | 840,000 | n/a | ||
| Avg | 306,000 | 408,000 | n/a | ||
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 180.0% | 174.5% | - | ||
| Avg | 36.0% | 33.3% | - | ||
| Low | - | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -1.51 | -0.74 | -0.70 | ||
| Avg | -1.62 | -1.40 | -0.68 | ||
| Low | -1.71 | -2.01 | -0.66 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.